Carisma Therapeutics Inc.

06/27/2024 | Press release | Distributed by Public on 06/27/2024 14:35

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.